Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9291 |
High Similarity |
NPD3027 |
Phase 3 |
0.8647 |
High Similarity |
NPD1613 |
Approved |
0.8647 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8537 |
High Similarity |
NPD5283 |
Phase 1 |
0.8374 |
Intermediate Similarity |
NPD228 |
Approved |
0.837 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.837 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8346 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8271 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8271 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8231 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8211 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8211 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8106 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7961 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7902 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7902 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7887 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD37 |
Approved |
0.7842 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7842 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.784 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7836 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7836 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7829 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7826 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.782 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7761 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7746 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7737 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7734 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7722 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7704 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7697 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7687 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7676 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD4538 |
Approved |
0.766 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7639 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7603 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7597 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7591 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7589 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7556 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7551 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7519 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7518 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7517 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7517 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6653 |
Approved |
0.748 |
Intermediate Similarity |
NPD290 |
Approved |
0.748 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7448 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7447 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7445 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7426 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7424 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7415 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7413 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.741 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7407 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7402 |
Intermediate Similarity |
NPD968 |
Approved |
0.74 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7394 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7376 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7376 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7375 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7375 |
Intermediate Similarity |
NPD27 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD291 |
Approved |
0.7355 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7355 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7351 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7351 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD52 |
Approved |
0.7349 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7325 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7324 |
Intermediate Similarity |
NPD3145 |
Approved |
0.732 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7319 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7315 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7305 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.726 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3686 |
Approved |
0.725 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7236 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7236 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7234 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7233 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7203 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7194 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7194 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7192 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7188 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7171 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7162 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7162 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7162 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7154 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7154 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7154 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7153 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7153 |
Intermediate Similarity |
NPD9384 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7132
|
Intermediate Similarity |
NPD1182 |
Approved |